Alaunos Therapeutics Appoints New Chief Medical Officer
Ticker: TCRT · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1107421
| Field | Detail |
|---|---|
| Company | Alaunos Therapeutics, INC. (TCRT) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, personnel
TL;DR
Alaunos Therapeutics names Dr. S. Robin Cohen as new CMO, effective April 13, 2025.
AI Summary
Alaunos Therapeutics, Inc. announced on April 15, 2025, that its Board of Directors appointed Dr. S. Robin Cohen as Chief Medical Officer, effective April 13, 2025. Dr. Cohen will also serve as a member of the company's management team. This appointment is part of the company's ongoing efforts to advance its therapeutic programs.
Why It Matters
The appointment of a new Chief Medical Officer is a key leadership change that could impact the strategic direction and execution of Alaunos Therapeutics' drug development pipeline.
Risk Assessment
Risk Level: medium — Leadership changes, especially in critical roles like CMO, can introduce uncertainty regarding future strategy and execution, impacting investor confidence.
Key Players & Entities
- Alaunos Therapeutics, Inc. (company) — Registrant
- Dr. S. Robin Cohen (person) — Appointed Chief Medical Officer
- April 15, 2025 (date) — Report Date
- April 13, 2025 (date) — Effective Date of Appointment
FAQ
Who has been appointed as the new Chief Medical Officer of Alaunos Therapeutics, Inc.?
Dr. S. Robin Cohen has been appointed as the new Chief Medical Officer of Alaunos Therapeutics, Inc.
When was the appointment of the new Chief Medical Officer effective?
The appointment of Dr. S. Robin Cohen as Chief Medical Officer was effective April 13, 2025.
What is the name of the company filing this report?
The company filing this report is Alaunos Therapeutics, Inc.
What is the former name of Alaunos Therapeutics, Inc.?
The former name of Alaunos Therapeutics, Inc. was ZIOPHARM ONCOLOGY INC.
What is the business address of Alaunos Therapeutics, Inc.?
The business address of Alaunos Therapeutics, Inc. is 2617 Bissonnet Street, Suite 225, Houston, Texas 77005.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 by Dr. S. Robin Cohen regarding Alaunos Therapeutics, Inc. (TCRT).